BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23769053)

  • 1. Donor-specific regulatory T cells generated on donor B cells are superior to CD4+CD25high cells in controlling alloimmune responses in humanized mice.
    Noyan F; Lee YS; Hardtke-Wolenski M; Knoefel AK; Taubert R; Baron U; Manns MP; Jaeckel E
    Transplant Proc; 2013 Jun; 45(5):1832-7. PubMed ID: 23769053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance.
    Jiang S; Tsang J; Lechler RI
    Transplant Proc; 2006 Dec; 38(10):3199-201. PubMed ID: 17175221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating naïve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis.
    Miyoshi H; Uchida K; Taniguchi T; Yazumi S; Matsushita M; Takaoka M; Okazaki K
    Pancreas; 2008 Mar; 36(2):133-40. PubMed ID: 18376303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injection of donor-derived OX62+ splenic dendritic cells with anti-CD4 monoclonal antibody generates CD4+CD25+FOXP3+ regulatory T cells that prolong allograft skin survival indefinitely and abrogate production of donor-specific antibodies in a rat model.
    Alawieh M; Rifle G; Bouchot O; Malapert G; Mousson C; Martin L
    Transplant Proc; 2009 Oct; 41(8):3363-6. PubMed ID: 19857750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25- FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia.
    Toldi G; Saito S; Shima T; Halmos A; Veresh Z; Vásárhelyi B; Rigó J; Molvarec A
    Am J Reprod Immunol; 2012 Aug; 68(2):175-80. PubMed ID: 22510013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential control of allo-antigen-specific regulatory T cells and effector T cells by anti-CD4 and other agents in establishing transplantation tolerance.
    Nagahama K; Fehervari Z; Oida T; Yamaguchi T; Ogawa O; Sakaguchi S
    Int Immunol; 2009 Apr; 21(4):379-91. PubMed ID: 19228878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation tolerance.
    Jiang S; Golshayan D; Tsang J; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1879-82. PubMed ID: 17161340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys.
    Ma A; Qi S; Song L; Hu Y; Dun H; Massicotte E; Dupuis M; Daloze P; Chen H
    Int Immunopharmacol; 2011 May; 11(5):618-29. PubMed ID: 21094689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The generation of donor-specific CD4+CD25++CD45RA+ naive regulatory T cells in operationally tolerant patients after pediatric living-donor liver transplantation.
    Nafady-Hego H; Li Y; Ohe H; Zhao X; Satoda N; Sakaguchi S; Wood K; Uemoto S; Koshiba T
    Transplantation; 2010 Dec; 90(12):1547-55. PubMed ID: 21085066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis reveals potency of CD4+ CD25bright+ regulatory T-cells in kidney transplant patients.
    Velthuis JH; Hesselink DA; Hendrikx TK; van der Mast BJ; Klepper M; de Greef GE; Baan CC; Weimar W
    Transpl Immunol; 2007 Nov; 18(2):159-65. PubMed ID: 18005862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells and B cells cooperate in the generation of CD4(+)CD25(+)FOXP3(+) allogeneic T cells.
    Moore C; Sauma D; Reyes PA; Morales J; Rosemblatt M; Bono MR; Fierro JA
    Transplant Proc; 2010; 42(1):371-5. PubMed ID: 20172352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.
    Ma A; Qi S; Wang Z; Massicotte E; Dupuis M; Daloze P; Chen H
    Int Immunopharmacol; 2009 May; 9(5):553-63. PubMed ID: 19539558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloantigen specific T regulatory cells in transplant tolerance.
    Hall BM; Tran G; Hodgkinson SJ
    Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro suppression of xenoimmune-mediated macrophage activation by human CD4+CD25+ regulatory T cells.
    Fu Y; Yi S; Wu J; Jimenez E; Simond D; Hawthorne WJ; O'Connell PJ
    Transplantation; 2008 Sep; 86(6):865-74. PubMed ID: 18813112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host CD25+CD4+Foxp3+ regulatory T cells primed by anti-CD137 mAbs inhibit graft-versus-host disease.
    Kim J; Kim W; Kim HJ; Park S; Kim HA; Jung D; Choi HJ; Park SJ; Mittler RS; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):44-54. PubMed ID: 21958951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo activated OVA specific and non-specific CD4+CD25+ regulatory T cells exhibit comparable suppression to OVA mediated T cell responses.
    Li J; Bracht M; Shang X; Radewonuk J; Emmell E; Griswold DE; Li L
    Cell Immunol; 2006 Jun; 241(2):75-84. PubMed ID: 17010326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.
    Teng L; Liu L; Su Y; Yuan X; Li J; Fu Q; Chen S; Wang C
    J Surg Res; 2011 Dec; 171(2):797-806. PubMed ID: 20538297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells.
    Fantini MC; Dominitzki S; Rizzo A; Neurath MF; Becker C
    Nat Protoc; 2007; 2(7):1789-94. PubMed ID: 17641646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.